These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29912681)

  • 41. Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.
    Rourke MF
    Milbank Q; 2019 Mar; 97(1):91-112. PubMed ID: 30637812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The global agenda on influenza surveillance and control.
    Stöhr K
    Vaccine; 2003 May; 21(16):1744-8. PubMed ID: 12686087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strengthening public health systems: assessing the attributes of the NSW influenza surveillance system.
    Dawson G; Gilmour R; Tobin S; Travaglia J
    Public Health Res Pract; 2016 Apr; 26(2):. PubMed ID: 27734064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.
    Nicoll A; Ammon A; Amato Gauci A; Ciancio B; Zucs P; Devaux I; Plata F; Mazick A; Mølbak K; Asikainen T; Kramarz P
    Public Health; 2010 Jan; 124(1):14-23. PubMed ID: 20141821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
    Navarro-Torné A; Hanrahan F; Kerstiëns B; Aguar P; Matthiessen L
    Emerg Infect Dis; 2019 Feb; 25(2):. PubMed ID: 30666948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT).
    Cox NJ; Trock SC; Burke SA
    Curr Top Microbiol Immunol; 2014; 385():119-36. PubMed ID: 25085014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are we ready for pandemic influenza?
    Webby RJ; Webster RG
    Science; 2003 Nov; 302(5650):1519-22. PubMed ID: 14645836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development and prospect of Influenza Surveillance Network in China].
    Wang DY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Aug; 39(8):1036-1040. PubMed ID: 30180424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease.
    Thompson WW; Comanor L; Shay DK
    J Infect Dis; 2006 Nov; 194 Suppl 2():S82-91. PubMed ID: 17163394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of mathematical models to inform influenza pandemic preparedness and response.
    Wu JT; Cowling BJ
    Exp Biol Med (Maywood); 2011 Aug; 236(8):955-61. PubMed ID: 21727183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Report of the international forum on pandemic influenza 2010 Qingdao, China, 24-25 July 2010.
    Varella A
    Vaccine; 2010 Nov; 28(48):7579-82. PubMed ID: 20887833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 65 years of influenza surveillance by a World Health Organization-coordinated global network.
    Ziegler T; Mamahit A; Cox NJ
    Influenza Other Respir Viruses; 2018 Sep; 12(5):558-565. PubMed ID: 29727518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenges of global surveillance during an influenza pandemic.
    Briand S; Mounts A; Chamberland M
    Public Health; 2011 May; 125(5):247-56. PubMed ID: 21524774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
    Weil-Olivier C; Lina B
    Vaccine; 2011 Sep; 29(40):7075-9. PubMed ID: 21777639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 56. Global influenza surveillance network:laboratory surveillance and response to pandemic H1N1 2009.
    Wkly Epidemiol Rec; 2009 Sep; 84(36):361-5. PubMed ID: 19764123
    [No Abstract]   [Full Text] [Related]  

  • 57. Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.
    Cowling BJ; Caini S; Chotpitayasunondh T; Djauzi S; Gatchalian SR; Huang QS; Koul PA; Lee PI; Muttalif AR; Plotkin S;
    Vaccine; 2017 Feb; 35(6):856-864. PubMed ID: 28081970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The WHO global influenza surveillance and response system (GISRS)-A future perspective.
    Hay AJ; McCauley JW
    Influenza Other Respir Viruses; 2018 Sep; 12(5):551-557. PubMed ID: 29722140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.
    Marcenac P; McCarron M; Davis W; Igboh LS; Mott JA; Lafond KE; Zhou W; Sorrells M; Charles MD; Gould P; Arriola CS; Veguilla V; Guthrie E; Dugan VG; Kondor R; Gogstad E; Uyeki TM; Olsen SJ; Emukule GO; Saha S; Greene C; Bresee JS; Barnes J; Wentworth DE; Fry AM; Jernigan DB; Azziz-Baumgartner E
    Emerg Infect Dis; 2022 Dec; 28(13):S26-S33. PubMed ID: 36502434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.
    Fowlkes A; Steffens A; Temte J; Lonardo SD; McHugh L; Martin K; Rubino H; Feist M; Davis C; Selzer C; Lojo J; Oni O; Kurkjian K; Thomas A; Boulton R; Bryan N; Lynfield R; Biggerstaff M; Finelli L;
    Lancet Respir Med; 2015 Sep; 3(9):709-718. PubMed ID: 26300111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.